Trial Profile
Planned phase I trial of visceral leishmaniasis vaccine [LEISH-F3] + GLA-SE adjuvant in healthy Indian adults
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Feb 2012
Price :
$35
*
At a glance
- Drugs LEISH-F3 peptide vaccine (Primary) ; Glycopyranosyl lipid adjuvant
- Indications Leishmaniasis
- Focus Adverse reactions
- 24 Feb 2012 New trial record